NCT00034827 - A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | Biotech Hunter

Enrollment

172

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

May 31, 2003

Conditions

Colorectal NeoplasmsBreast NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms

Interventions

DRUG

CI-1040

Trial Locations (30)

30033

Pfizer Investigational Site, Decatur

30342

Pfizer Investigational Site, Atlanta

Pfizer Investigational Site, Macon

35205

Pfizer Investigational Site, Birmingham

35233

Pfizer Investigational Site, Birmingham

41017

Pfizer Investigational Site, Crestview Hills

45219

Pfizer Investigational Site, Cincinnati

45230

Pfizer Investigational Site, Cincinnati

45236

Pfizer Investigational Site, Cincinnait

45242

Pfizer Investigational Site, Cincinnati

48201

Pfizer Investigational Site, Detroit

55905

Pfizer Investigational Site, Rochester

90048

Pfizer Investigational Site, Los Angeles

90095

Pfizer Investigational Site, Los Angeles

90277

Pfizer Investigational Site, Redondo Beach

90404

Pfizer Investigational Site, Santa Monica

90505

Pfizer Investigational Site, Torrance

90720

Pfizer Investigational Site, Los Alamitos

90813

Pfizer Investigational Site, Long Beach

91105

Pfizer Investigational Site, Pasadena

91204

Pfizer Investigational Site, Glendale

91328

Pfizer Investigational Site, Northridge

91345

Pfizer Investigational Site, Mission Hills

91730

Pfizer Investigational Site, Rancho Cucamonga

91740

Pfizer Investigational Site, Blendora

91767

Pfizer Investigational Site, Pomona

91790

Pfizer Investigational Site, West Covina

92648

Pfizer Investigational Site, Huntington Beach

93003

Pfizer Investigational Site, Ventura

93030

Pfizer Investigational Site, Oxnard